Post-stroke epilepsy and risk of all-cause mortality: A systematic review and meta-analysis of cohort studies - PubMed
Meta-Analysis
Post-stroke epilepsy and risk of all-cause mortality: A systematic review and meta-analysis of cohort studies
Zhong Ren et al. Clin Neurol Neurosurg. 2022 Sep.
Abstract
Objective: Post-stroke epilepsy (PSE) has been suggested as a predictor of poor prognosis. We aimed to evaluate the association between PSE and all-cause mortality via a meta-analysis.
Methods: Relevant cohort studies were identified by search of electronic databases including PubMed, Embase, and Web of Science. Two authors independently performed database search, data collection, and study quality evaluation. A randomized-effect model incorporating the possible between-study heterogeneity was used to pool the results.
Results: Overall, ten cohort studies including 177,929 patients with stroke contributed to the meta-analysis. Of them, 15,836 (8.9%) had PSE during a mean follow-up of 4 years. Compared to stroke survivors without PSE, patients with PSE had a significantly increased risk of all-cause death (odds ratio [OR]: 1.68, 95% confidence interval: 1.51-1.87, p < 0.001; I2 = 80%). Subgroup analyses showed consistent association in patients with ischemic and hemorrhagic stroke, in prospective and retrospective studies, in PSE diagnosed as unprovoked seizure occurred more than 7 days and 14 days after stroke, in studies with follow-up durations within or over 5 years, and in studies with different quality scores (p for subgroup effect all < 0.05). The Galbraith plot identified three outlier studies which may contribute to the heterogeneity of the meta-analysis, and all of the three studies were database-linked studies. The between-study heterogeneity was significantly reduced after removing the three database-linked studies (OR: 1.39, 95% CI: 1.18-1.62, p < 0.001; I2 = 0%).
Conclusion: PSE was associated with a higher risk of all-cause mortality.
Keywords: All-cause mortality; Intracerebral hemorrhage; Ischemic stroke; Meta-analysis; Post-stroke epilepsy.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declared that they have no potential conflict of interest.
Similar articles
-
Nandan A, Zhou YM, Demoe L, Waheed A, Jain P, Widjaja E. Nandan A, et al. J Int Med Res. 2023 Nov;51(11):3000605231213231. doi: 10.1177/03000605231213231. J Int Med Res. 2023. PMID: 38008901 Free PMC article.
-
Post-stroke epilepsy in an ischemic stroke cohort-Incidence and diagnosis.
Hassani M, Cooray G, Sveinsson O, Cooray C. Hassani M, et al. Acta Neurol Scand. 2020 Feb;141(2):141-147. doi: 10.1111/ane.13174. Epub 2019 Oct 22. Acta Neurol Scand. 2020. PMID: 31580473
-
Statin on post-stroke epilepsy: A systematic review and meta-analysis.
Fang J, Tuo M, Ouyang K, Xu Y. Fang J, et al. J Clin Neurosci. 2021 Jan;83:83-87. doi: 10.1016/j.jocn.2020.11.023. Epub 2020 Dec 15. J Clin Neurosci. 2021. PMID: 33339690
-
Gasparini S, Ascoli M, Brigo F, Cianci V, Branca D, Arcudi L, Aguglia U, Belcastro V, Ferlazzo E. Gasparini S, et al. Epilepsy Behav. 2020 Mar;104(Pt B):106540. doi: 10.1016/j.yebeh.2019.106540. Epub 2019 Oct 31. Epilepsy Behav. 2020. PMID: 31677999 Review.
-
Statin use and the risk of post-stroke seizures: A meta-analysis.
Xu T, Wang Y, Yuan J, Chen Y, Luo H. Xu T, et al. Seizure. 2020 Dec;83:63-69. doi: 10.1016/j.seizure.2020.10.004. Epub 2020 Oct 13. Seizure. 2020. PMID: 33096458 Review.
Cited by
-
Chen J, Huang F, Fang X, Li S, Liang Y. Chen J, et al. Open Life Sci. 2022 Dec 27;17(1):1689-1697. doi: 10.1515/biol-2022-0526. eCollection 2022. Open Life Sci. 2022. PMID: 36619717 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical